Lundbeck to highlight mechanistic insights on bexicaserin's dual mode of action at the European Epilepsy Congress

Summary

Lundbeck will present preclinical mechanistic data on bexicaserin at the European Epilepsy Congress, demonstrating its dual mode of action in inhibiting excitatory while enhancing inhibitory neuronal activity across multiple seizure models.